Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. - Wikidata - wikimedia - TriplyDB

Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.

Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.

http://www.wikidata.org/entity/Q33299294

about

Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement Anti-Stokes fluorescence from endogenously formed protoporphyrin IX--implications for clinical multiphoton diagnostics.Iron chelators in photodynamic therapy revisited: synergistic effect by novel highly active thiosemicarbazones."Triple Observation Method (TOM)" to discriminate optically autofluorescence from porphyrins versus that from copper-metallothioneins.The origins of urothelial carcinoma.In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.Nickel(II) chelatase variants directly evolved from murine ferrochelatase: porphyrin distortion and kinetic mechanism.Diagnostic accuracy of diffuse reflectance imaging for early detection of pre-malignant and malignant changes in the oral cavity: a feasibility study Techniques for fluorescence detection of protoporphyrin IX in skin cancers associated with photodynamic therapy.Differentiation of healthy and malignant tissue in colon cancer patients using optical spectroscopy: A tool for image-guided surgery.Detection of cervical lesions by multivariate analysis of diffuse reflectance spectra: a clinical study.ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton irradiation and treatments with oxidant agents and flavonoids Multispectral autofluorescence imaging for detection of cervical lesions: A preclinical study.Merging molecular imaging and RNA interference: early experience in live animals Chronic Treatment with Isoniazid Causes Protoporphyrin IX Accumulation in Mouse Liver.5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression.Expression of Genes Involved in Porphyrin Biosynthesis Pathway in the Human Renal Cell Carcinoma.Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin.Sodium butyrate increases the effect of the photodynamic therapy: a mechanism that involves modulation of gene expression and differentiation in astrocytoma cells.Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug.Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937.A comparative evaluation of diffuse reflectance and Raman spectroscopy in the detection of cervical cancer.5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study.Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma.Assessing the efficacy of coherent anti-Stokes Raman scattering microscopy for the detection of infiltrating glioblastoma in fresh brain samples.Native fluorescence spectroscopic characterization of DMBA induced carcinogenesis in mice skin for the early detection of tissue transformation.Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.[Advances in endoscopic diagnosis of dysplasia and carcinoma of the larynx].Early detection of colorectal adenocarcinoma: a clinical decision support tool based on plasma porphyrin accumulation and risk factors

P2860

Q26777817-07C541FC-F762-4F04-B1D7-969DA807D6D0 Q31097376-B40C9D62-B76E-4715-BAF7-CD56E75FCEA9 Q33636546-87293A50-77CF-4BE8-857D-B68BFF30AAF2 Q33755814-51A590F4-F778-4067-80FF-8125B31B3D03 Q34121078-7DE62B47-A8CF-4DF4-B5DB-7C22766E7AB6 Q34517469-77891363-4572-42F0-82A8-16F6BEBAE0D6 Q34631621-98A2FCB5-C760-42B7-AFCE-6C298EB72102 Q34759293-814A2472-329C-4FAE-B445-1676FB75E221 Q34972188-8BD5E80A-A043-44A4-B65C-F3E77AC562CD Q35699287-FD54527A-48EE-475D-A618-FDB42E549C68 Q35828616-60615D75-16F4-45EB-A350-93AE43B0D91E Q35964440-50A998F5-C8C8-462A-9353-DDA4BFF3A2FA Q36095911-00CCC04E-0ACA-416F-96D1-1899B07B5443 Q36164929-88341D3E-3184-4162-9196-95DF1227188F Q37076203-7BD7209F-57F6-402E-AA78-AD3E591E9595 Q37651213-95C8BFB2-2008-41E2-9AE4-ABC823609271 Q37687070-B645E704-3E34-4D6B-AA05-63680F5AA932 Q38846132-D250FC6C-EAB5-4CFC-A591-A109F8A2DAC6 Q38895066-8A13548C-3579-4B78-9E32-995AF5A7B295 Q39001465-3CA2355A-AB14-4F37-8DA7-9155A1BA5B93 Q39329059-653B1BDA-58E0-4F83-8A7F-CE2833DE720C Q39454241-A6A0EFED-8AA7-49C5-8416-A1398450D74E Q39487686-99DD5309-7F41-450D-8EF3-74A1226E7076 Q39595667-6BCD2F78-3197-42AA-936D-D9B66EA41820 Q39802713-A2133D1C-37E1-49CC-872A-9177B56DB6D6 Q39957987-AD0AE79B-C184-43BB-B2CE-0CADEBA0746B Q45777369-5FB5047D-24A5-44F6-B53A-8571E12644A4 Q45851185-D17115B9-2CAD-464F-9931-CF1B5D3C162A Q48427414-D0AADFAE-00DD-4326-99EE-0DE947760E32 Q50851948-2DA35BF2-7DE4-46BF-A579-0FD72B848AA2 Q52714390-3F35A9F2-1A59-4DFF-8BB2-6A6B112C7D69 Q53178343-0D5E63E5-ED79-459E-BDEA-7B86D21299E1 Q57167926-CD619CA2-6389-4D5E-9031-EED8F78F57EB

P2860

Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.

http://www.wikidata.org/entity/Q33299294

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Silencing of human ferrochelat ...... accumulation in colon cancer.

@ast

Silencing of human ferrochelat ...... accumulation in colon cancer.

@en

Silencing of human ferrochelat ...... accumulation in colon cancer.

@nl

type

label

Silencing of human ferrochelat ...... accumulation in colon cancer.

@ast

Silencing of human ferrochelat ...... accumulation in colon cancer.

@en

Silencing of human ferrochelat ...... accumulation in colon cancer.

@nl

prefLabel

Silencing of human ferrochelat ...... accumulation in colon cancer.

@ast

Silencing of human ferrochelat ...... accumulation in colon cancer.

@en

Silencing of human ferrochelat ...... accumulation in colon cancer.

@nl

P1433

Q33299294-CDB89E48-FCF8-4BAA-ABE0-639EE245B930

P1476

Q33299294-F347815A-121F-4424-B59B-01796A4DC506

P2093

Q33299294-30C41D1E-58C0-4780-9EEA-FF7E75FEFB44

Q33299294-3649026D-A6A2-4F30-AF4B-90E9DE1519BF

Q33299294-857E9500-5157-424B-B719-E808239DE281

Q33299294-98A7215C-B091-4767-8D60-549E496A1586

Q33299294-CB6A1584-9BEC-4637-89F0-F49ECD848526

Q33299294-D0DE9992-28FA-492A-BCEB-95F58455C69C

Q33299294-DEBEF6C8-9556-49BE-BFF6-5AB0B2DFE6B8

P304

Q33299294-91C35FF0-767E-4673-B3B2-5FAE0A8C8CE1

P31

Q33299294-82C0E2DB-88BA-4E31-8A12-9CE9688309D8

P356

Q33299294-81278732-3F49-4E17-9B75-B456467966A2

P407

Q33299294-8C34635F-0826-40CE-801A-73024BB750C7

P433

Q33299294-BDBDFB78-4DBF-4511-B091-61AE0AA5B9BE

P478

Q33299294-3F5CB7D3-5E55-4489-A231-8A6E3C5E75FD

P577

Q33299294-D822BE73-AF35-48A2-BECB-3D31854991C1

P5875

Q33299294-0E9BF76D-5BFD-4808-A05E-471C65099C32

P698

Q33299294-FBD2A634-6353-4F52-B4BC-61EAE6D18D8E

P356

P1433

P1476

Silencing of human ferrochelat ...... accumulation in colon cancer.

@en

P2093

Bernd Ebert

http://www.w3.org/2001/XMLSchema#string

K Thomas Moesta

http://www.w3.org/2001/XMLSchema#string

Kayiu Wan

http://www.w3.org/2001/XMLSchema#string

Rainer Macdonald

http://www.w3.org/2001/XMLSchema#string

Steffen Rüttinger

http://www.w3.org/2001/XMLSchema#string

Ursula Klamm

http://www.w3.org/2001/XMLSchema#string

Wolfgang Kemmner

http://www.w3.org/2001/XMLSchema#string

P304

500-509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.07-8888COM

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5966652

http://www.w3.org/2001/XMLSchema#string

P698

17875605

http://www.w3.org/2001/XMLSchema#string